Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise


Global ROS1 Initiative Combines Patient Experience with Researcher Expertise to Target ROS1 Cancer Wherever It Grows

University of Colorado Cancer Center study presented at AACR 2018 describes new model for patient-researcher collaboration organized not around cancer type but around oncogene that causes many cancers
9-Apr-2018 12:00 PM EDT Add to Favorites


Beyond PD-L1: Taking Away TIM3 and Tregs Stops Cancer Regrowth After Immunotherapy

CU Cancer Center study presented at AACR18 shows that TIM3 and/or increased regulatory T cells (Tregs) within a tumor may help cancers inactivate immune system killer T cells that would otherwise identify and attack the cancer.
9-Apr-2018 1:05 PM EDT Add to Favorites


When Prostate Cancer Reaches Bone, Bone Cells May Drive Overall Growth of the Disease

When prostate cancer metastasizes to bone, it can become especially dangerous – CU Cancer Center study at AACR18 hints at why: Cells involved in these bone metastases may release signals that drive the progression of the disease.
9-Apr-2018 2:05 PM EDT Add to Favorites


How Do Melanoma Cells Survive Drug Treatment Long Enough to Acquire Drug Resistance?

University of Colorado Cancer Center study presented at AACR 2018 shows that even within three days of treatment, melanoma cells find a way to activate MEK – not with mutations, but with a more flexible and temporary way to allow these cancer...
9-Apr-2018 3:05 PM EDT Add to Favorites


Cancer Comes Back All Jacked Up on Stem Cells

Three tumor samples collected over time from a single patient show how cancer evolves in response to treatment.
19-Mar-2018 4:00 PM EDT Add to Favorites


Here's How Viruses Inactivate the Immune System, Causing Cancer

"The same mechanisms that viruses use to cause cancer may be key in combating tumors with immune-based therapies or in keeping cancer from developing in the first place," says Sharon Kuss-Duerkop, PhD.
2-Mar-2018 8:05 AM EST Add to Favorites


Expert Panel Issues New Guidelines for Lung Cancer Molecular Testing

Experts from three major organizations add ROS1 to list of tests matching lung cancer with targeted treatments.
30-Jan-2018 11:05 AM EST Add to Favorites


Study Suggests PD-1 Inhibitors Against Aggressive Pediatric Brain Cancer Subtype

A University of Colorado Cancer Center study published in the journal Pediatric Blood Cancers lays the scientific groundwork for the use of PD-1 inhibitors with an aggressive form of brain cancer, namely supratentorial pediatric ependymoma.
29-Jan-2018 11:05 AM EST Add to Favorites

see all news

Our Experts on Newswise


Will One Bad Sunburn Give You Skin Cancer?

27-Jul-2015 11:05 AM EDT


Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing

An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!